comparemela.com

Latest Breaking News On - Larry latson - Page 1 : comparemela.com

Memorial Cardiac and Vascular Institute is First in South Florida to Use 'Harmony' for Valve Replacement

Memorial Cardiac and Vascular Institute is First in South Florida to Use 'Harmony' for Valve Replacement
dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.

Florida
United-states
Deerfield-beach
Marc-chatzky
Larry-latson
Tom-forbes
Todd-roth
Peter-guyon
Vascular-institute
Memorial-cardiac
Adult-congenital-heart-disease
Joe-dimaggio-children

Advancing Cardiac Care: Memorial Cardiac and Vascular Institute is First in South Florida to Use 'Harmony' for Valve Replacement

HOLLYWOOD, Fla. (PRWEB) June 17, 2022 Marc Chatzky may not feel like a cardiac pioneer, but he is, at least in South Florida. The Deerfield Beach resident

Florida
United-states
Hollywood
California
Deerfield-beach
Marc-chatzky
Larry-latson
Tom-forbes
Todd-roth
Peter-guyon
Vascular-institute
Memorial-cardiac-vascular-institute

Surgeons Use Novel Occluder with a Metal-Free Frame on a Patient with ASD

Joe DiMaggio Children's Hospital Heart Surgeons Use Novel Occluder with a Metal-Free Frame on a Patient with ASD or Hole in the Heart Under Pivotal U.S. IDE Trial

Hollywood, Fla (PRWEB) May 04, 2022 Joe DiMaggio Children’s Hospital recently announced the successful treatment of a patient with atrial septal defects

California
United-states
Florida
Hollywood
Thousand-oaks
Switzerland
Larry-latson
Laurent-grandidier
Saibal-kar
Instagram
Twitter
Pediatric-congenital-interventional-cardiology-program-co

Newly Formed Company, atHeart Medical, Aims to Evolve Septal Closure with the reSept™ ASD Occluder

Newly Formed Company, atHeart Medical, Aims to Evolve Septal Closure with the reSept™ ASD Occluder Company prepares for U.S. IDE clinical trial of its novel metal-free frame designed to reduce complications and preserve long-term treatment options News provided by Share this article Share this article BAAR, Switzerland and MOUNTAIN VIEW, Calif., April 20, 2021 /PRNewswire/  atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal defects (ASD), announced today that it has commenced operations and is initiating its U.S. Investigational Device Exemption (IDE) trial. The company is led by seasoned global medtech executive, Laurent Grandidier, with support from an exceptional management team that has decades of experience with medical device start-ups and major corporations.

Florida
United-states
Switzerland
Swiss
Larry-latson
Laurent-grandidier
Katie-arnold
Olle-larsson-holding
Company-data-on-file
Heart-medical
Co-principal-investigator
Pediatric-interventional-cardiology

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.